Emerging evidence suggests that higher circulating levels of IL-6 are significantly associated with an elevated risk of AF recurrence following cardioversion [17,18] and after radiofrequency catheter ablation [19], with poorer long-term outcomes, including greater risk of stroke and all-cause mortality [20]. The gene discussed is IL6; the disease is stroke disorder.